Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYDY - FDA OKs CytoDyn's mid-stage leronlimab trial

CYDY - FDA OKs CytoDyn's mid-stage leronlimab trial

CytoDyn Inc
  • CytoDyn (OTCQB:CYDY) announces FDA clearance to initiate enrollment in its Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
  • More news on: CytoDyn Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...